{"id":"exp-1-data-minimalism","title":"Data Minimalism vs. Data Maximalism for Rare Disease Drug Repurposing","assumption":"Data Maximalism Assumption - more comprehensive multi-modal datasets always improve repurposing predictions","hypothesis":"H1: Minimal but highly curated datasets achieve superior actionable predictions compared to comprehensive multi-modal approaches","evaluationPlan":"AI agent automated pipeline: (1) Download and preprocess DrugBank, ChEMBL, OMIM, GTEx datasets, (2) Train comprehensive model with >10K features vs minimal model with <500 curated features, (3) Automated evaluation on 50 rare diseases with known outcomes, (4) Statistical significance testing with automated early stopping if minimal approach fails on >80% of diseases","implications":"Could unlock repurposing for ultra-rare conditions with extremely limited data and establish data quality over quantity principles for all biomedical AI","relatedWork":"Drug repurposing studies using multi-modal integration, feature selection for biomedical prediction, clinical actionability in AI systems","milestones":"Week 2: Automated data pipelines complete, Week 8: Parallel model training complete, Week 10: Comprehensive evaluation complete, Week 12: Statistical analysis and assumption validation complete","successCriteria":"Strong: >20% better actionable accuracy (p<0.01), Moderate: >10% improvement (p<0.05), Failure triggers automated investigation of data quality thresholds","priority":"high","status":"proposed","notes":"Foundation experiment with automated vectoring - highest risk assumption that could invalidate entire minimalist approach","aiExecutable":"true","vectoringRisk":"highest","automationProtocol":"Fully automated data pipelines, model training, evaluation, and statistical analysis with real-time early stopping rules","createdDate":"2025-08-13T05:22:16Z"}
{"id":"exp-2-actionability-first","title":"Actionability-First vs. Accuracy-First AI Design","assumption":"Accuracy-First Assumption - predictive accuracy is the primary success metric for AI systems","hypothesis":"H2: Models designed for clinical actionability (interpretability, uncertainty quantification, decision support) outperform accuracy-optimized models in clinical outcomes","evaluationPlan":"Retrospective analysis of clinical decision-making with 100 rare disease cases. Compare traditional accuracy-optimized models vs. actionability-optimized models with interpretability and uncertainty quantification. Measure clinical adoption rate, patient outcomes, and physician confidence.","implications":"Could bridge the gap between AI predictions and clinical implementation, establishing new evaluation standards for medical AI","relatedWork":"Explainable AI in healthcare, clinical decision support systems, uncertainty quantification in medical prediction","milestones":"Week 8: Model development complete, Week 14: Clinical evaluation complete, Week 16: Analysis complete","successCriteria":"Clinical adoption rate >40% higher, patient outcomes >20% improvement, physician confidence >30% higher","priority":"high","status":"proposed","notes":"Critical for clinical translation - tests whether accuracy is the right optimization target","createdDate":"2025-08-13T05:22:16Z"}
{"id":"exp-3-cross-disease-transfer","title":"Cross-Disease Transfer Learning vs. Disease-Specific Models","assumption":"Disease-Specific Modeling Assumption - each rare disease requires custom computational approaches","hypothesis":"H3: Transfer learning models leveraging shared mechanistic patterns outperform disease-specific models, especially for ultra-rare conditions with limited data","evaluationPlan":"Compare disease-specific models vs. meta-learning models across three data availability scenarios: high-data (>1000 patients), low-data (100-999 patients), and ultra-rare (<100 patients). Evaluate prediction accuracy, generalization, and training efficiency.","implications":"Could enable repurposing for diseases with insufficient individual datasets by leveraging cross-disease patterns","relatedWork":"Transfer learning in biomedical domains, meta-learning for few-shot prediction, cross-disease analysis","milestones":"Week 12: Model development complete, Week 18: Evaluation complete, Week 20: Analysis complete","successCriteria":"Ultra-rare disease accuracy improvement >35%, generalization score >0.75, training efficiency >50% improvement","priority":"high","status":"proposed","notes":"Key for scaling to ultra-rare diseases with minimal data","createdDate":"2025-08-13T05:22:16Z"}
{"id":"exp-4-parallel-validation","title":"Parallel vs. Sequential Validation Strategies","assumption":"Sequential Validation Assumption - drug validation must follow linear preclinical → clinical stages","hypothesis":"H4: Parallel multi-stage validation using real-world evidence achieves equivalent safety validation in significantly less time","evaluationPlan":"Retrospective analysis of historical drug repurposing cases comparing traditional sequential validation vs. parallel validation using real-world evidence and computational modeling. Measure time-to-decision, safety signal detection, and resource efficiency.","implications":"Could dramatically reduce time-to-treatment for rare disease patients while maintaining safety standards","relatedWork":"Real-world evidence in drug development, regulatory science, accelerated approval pathways","milestones":"Week 16: Protocol development complete, Week 22: Retrospective analysis complete, Week 24: Reporting complete","successCriteria":"Time reduction >60% while maintaining safety, safety signal detection ≥95% of sequential method, resource efficiency >40%","priority":"medium","status":"proposed","notes":"Tests regulatory pathway assumptions - requires partnership with regulatory scientists","createdDate":"2025-08-13T05:22:16Z"}
{"id":"exp-5-human-ai-collaboration","title":"Human-AI Collaboration vs. Fully Automated Systems","assumption":"AI Supremacy Assumption - AI should minimize human bias and replace expert judgment","hypothesis":"H5: Collaborative human-AI systems leveraging irreplaceable rare disease expertise outperform fully automated approaches for complex repurposing decisions","evaluationPlan":"AI agent simulation: (1) Build fully automated repurposing system, (2) Implement human-AI collaborative interface with expert simulation, (3) Automated A/B testing across 200 drug repurposing cases with known ground truth, (4) Categorize decisions by complexity and measure quality differences","implications":"Could leverage irreplaceable rare disease expertise while scaling discovery, establishing optimal human-AI collaboration models","relatedWork":"Human-AI collaboration, clinical decision support, expert systems in medicine","milestones":"Week 4: Automated and collaborative systems complete, Week 12: Comparative evaluation complete, Week 16: Decision complexity analysis complete, Week 18: Collaboration optimization complete","successCriteria":"Strong: >35% better decision quality on complex cases, Moderate: >20% improvement with acceptable efficiency, Failure triggers investigation of AI capability limits","priority":"medium","status":"proposed","notes":"Tests fundamental assumption about AI replacing vs. amplifying human expertise - uses expert simulation for AI agent execution","aiExecutable":"true","vectoringRisk":"medium","automationProtocol":"Expert simulation based on clinical decision patterns, automated A/B testing, real-time performance monitoring","createdDate":"2025-08-13T05:22:16Z"}
{"id":"micro-exp-b-actionability-ablation","title":"Actionability Feature Ablation Study","assumption":"Unclear which actionability features contribute most to clinical utility","hypothesis":"Specific actionability features (interpretability vs uncertainty vs decision support) have differential impacts on clinical outcomes","evaluationPlan":"Automated ablation study systematically removing actionability features and measuring clinical utility scores. Test interpretability (SHAP/LIME), uncertainty quantification, and decision support features independently.","implications":"Optimizes actionability feature selection to maximize clinical utility while minimizing computational overhead","relatedWork":"Ablation studies in explainable AI, clinical utility measurement, feature importance analysis","milestones":"Day 1: Baseline actionable model, Day 2: Automated ablation testing, Day 3: Feature importance ranking","successCriteria":"Rank actionability features by clinical utility contribution and identify minimum viable feature set","priority":"medium","status":"proposed","notes":"Fast identification of most important actionability features for clinical AI systems","aiExecutable":"true","vectoringRisk":"low","automationProtocol":"Automated feature ablation with clinical utility scoring","timelineWeeks":"0.5","createdDate":"2025-08-13T05:39:45Z"}
{"id":"exp-6-complexity-implementation","title":"Computational Complexity vs. Clinical Implementation Success","assumption":"Complexity Superiority Assumption - more sophisticated models achieve better clinical outcomes than simple approaches","hypothesis":"H6: Simple, interpretable models with clinical workflow optimization outperform complex architectures in real-world deployment","evaluationPlan":"AI agent automated comparison: (1) Build simple baseline (logistic regression, random forest) with extensive feature engineering, (2) Build complex baseline (GNNs, transformers) with minimal feature engineering, (3) Create workflow-optimized simple model with clinical integration, (4) Simulate clinical deployment with realistic constraints and measure total clinical impact (accuracy × adoption × implementation speed)","implications":"Could democratize AI drug repurposing and accelerate clinical adoption globally through interpretable, deployable models","relatedWork":"Model complexity vs interpretability trade-offs, clinical AI adoption studies, workflow integration research","milestones":"Week 4: Architecture development complete, Week 12: Deployment simulation complete, Week 16: Comparative evaluation complete, Week 18: Clinical impact analysis complete","successCriteria":"Strong: >30% higher total clinical impact, Moderate: Match accuracy with >50% better adoption, Failure triggers investigation of hybrid complexity approaches","priority":"high","status":"proposed","notes":"Tests fundamental assumption about computational sophistication correlating with clinical success","aiExecutable":"true","vectoringRisk":"high","automationProtocol":"Automated architecture comparison with clinical deployment simulation and adoption modeling","createdDate":"2025-08-14T18:24:42Z"}
{"id":"exp-7-mechanistic-patterns","title":"Mechanistic Understanding vs. Pattern Matching for Clinical Success","assumption":"Pattern Matching Sufficiency Assumption - statistical associations are sufficient for effective drug repurposing without mechanistic understanding","hypothesis":"H7: Mechanistically-informed AI incorporating biological pathway knowledge achieves superior clinical success rates","evaluationPlan":"AI agent automated comparison: (1) Build pattern-matching baseline using standard ML on molecular/clinical features, (2) Develop mechanistic model incorporating pathway databases (KEGG, Reactome), protein interaction networks, (3) Create hybrid model combining patterns with mechanism constraints, (4) Test across diseases categorized by mechanism understanding level (well-understood, partially-understood, unknown)","implications":"Establishes scientific rationale requirement for clinical AI, affecting entire medical AI field by requiring mechanistic grounding","relatedWork":"Knowledge-guided machine learning, pathway-based drug discovery, mechanistic modeling in systems biology","milestones":"Week 6: Mechanistic knowledge integration complete, Week 12: Hybrid model development complete, Week 18: Disease stratification evaluation complete, Week 20: Mechanistic advantage analysis complete","successCriteria":"Strong: >25% better performance on well-understood diseases with superior physician adoption, Moderate: >15% improvement with better explanation quality, Failure triggers investigation of mechanistic knowledge quality","priority":"high","status":"proposed","notes":"Tests whether AI needs biological understanding or statistical patterns are sufficient for clinical success","aiExecutable":"true","vectoringRisk":"high","automationProtocol":"Automated pathway integration, disease mechanism stratification, and clinical translation simulation","createdDate":"2025-08-14T18:24:42Z"}
{"id":"exp-8-prospective-retrospective","title":"Prospective Clinical Validation vs. Retrospective Benchmark Performance","assumption":"Benchmark Predictivity Assumption - performance on retrospective datasets predicts clinical success","hypothesis":"H8: Models optimized for prospective clinical metrics outperform benchmark-optimized models in real clinical settings","evaluationPlan":"AI agent dual optimization: (1) Train retrospective baseline optimized for standard benchmarks (AUC, precision, recall), (2) Develop prospective model optimized for clinical outcome prediction using realistic simulation, (3) Create meta-learning model balancing retrospective and prospective objectives, (4) Compare translation to simulated clinical success and adoption","implications":"Would fundamentally reshape evaluation standards for all medical AI research by establishing prospective validation as essential","relatedWork":"Clinical translation of AI models, prospective validation studies, benchmark-clinical outcome correlation analysis","milestones":"Week 8: Dual optimization frameworks complete, Week 16: Parallel evaluation complete, Week 20: Translation gap analysis complete, Week 24: Prospective validation complete","successCriteria":"Strong: >35% better simulated clinical outcomes with minimal retrospective loss, Moderate: >20% clinical improvement with acceptable benchmark trade-offs, Failure triggers investigation of benchmark clinical relevance","priority":"high","status":"proposed","notes":"Tests fundamental assumption about retrospective benchmark performance predicting clinical success","aiExecutable":"true","vectoringRisk":"highest","automationProtocol":"Automated dual optimization with realistic clinical simulation and translation gap analysis","createdDate":"2025-08-14T18:24:42Z"}
{"id":"exp-9-resource-constrained","title":"Resource-Constrained vs. Resource-Abundant AI Design","assumption":"Resource Abundance Assumption - optimal AI systems should use maximum computational resources for best performance","hypothesis":"H9: AI systems optimized for resource constraints achieve better global impact through increased accessibility and deployment","evaluationPlan":"AI agent multi-resource comparison: (1) Build high-resource baseline using maximum computational capacity (large models, extensive hyperparameter search, ensembles), (2) Develop resource-constrained model optimized for edge deployment, (3) Create adaptive architecture scaling with available resources, (4) Simulate global deployment across different resource contexts and calculate population-level health impact (performance × deployment reach)","implications":"Could democratize AI drug repurposing globally, especially in resource-limited healthcare systems serving rare disease populations","relatedWork":"Edge AI deployment, resource-efficient machine learning, global health technology access, mobile health applications","milestones":"Week 6: Multi-resource architectures complete, Week 12: Global deployment simulation complete, Week 18: Comparative evaluation complete, Week 20: Global impact analysis complete","successCriteria":"Strong: >50% higher global impact through increased accessibility, Moderate: Match total impact with better accessibility profiles, Failure triggers investigation of hybrid deployment strategies","priority":"medium","status":"proposed","notes":"Tests assumption about resource maximization vs. constraint optimization for global health impact","aiExecutable":"true","vectoringRisk":"medium","automationProtocol":"Automated multi-resource architecture development with global deployment simulation","createdDate":"2025-08-14T18:24:42Z"}
{"id":"exp-10-uncertainty-confidence","title":"Uncertainty-Aware vs. Confidence-Maximizing AI Systems","assumption":"Confidence Maximization Assumption - AI systems should maximize prediction confidence to ensure clinical adoption","hypothesis":"H10: Uncertainty-aware systems that honestly communicate prediction limitations achieve better clinical outcomes through appropriate use","evaluationPlan":"AI agent uncertainty comparison: (1) Build confidence-maximizing baseline optimizing for high-confidence predictions, (2) Develop uncertainty-aware model with calibrated confidence intervals and reliability scores, (3) Create adaptive system adjusting uncertainty communication based on decision context, (4) Simulate physician decision-making with different uncertainty presentations and measure clinical outcomes","implications":"Establishes honest uncertainty communication as essential for responsible medical AI, affecting field-wide practices","relatedWork":"Uncertainty quantification in machine learning, calibrated prediction intervals, physician decision-making under uncertainty","milestones":"Week 6: Uncertainty architectures complete, Week 12: Clinical decision simulation complete, Week 18: Comparative evaluation complete, Week 20: Uncertainty communication optimization complete","successCriteria":"Strong: >30% better clinical outcomes through appropriate usage, Moderate: >15% improvement in decision quality with maintained adoption, Failure triggers investigation of confidence calibration approaches","priority":"medium","status":"proposed","notes":"Tests assumption about confidence maximization vs. honest uncertainty communication for clinical AI","aiExecutable":"true","vectoringRisk":"medium","automationProtocol":"Automated uncertainty quantification with clinical decision simulation and outcome measurement","createdDate":"2025-08-14T18:24:42Z"}